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Long term Westernized diet leads to region-speciﬁc changes in brain
signaling mechanisms
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A B S T R A C T
Western diets, high in fat and energy, are associated with cognitive deﬁcits in humans and animal models, but
the underlying mechanisms are not fully elucidated. This includes whether diet-induced dyslipidemia per se
negatively impacts brain signaling. Here we investigate the eﬀects of dyslipidemia induced by two high fat diets
with or without high sucrose on hippocampal and frontal cortical oxidative stress, brain-derived neurotrophic
factor (BDNF) and down-stream markers of synaptic plasticity, as well as alterations in monoaminergic neuro-
transmitter levels. A high fat diet was associated with decreased antioxidant status (vitamin C), increased ser-
otonin in the frontal cortex, and increased ratio of phosphorylated Ca2+/calmodulin-dependent protein kinase II
in the hippocampus, while a high fat and sucrose diet decreased levels of vitamin C in the frontal cortex and
BDNF in the hippocampus. Markers of dyslipidemia correlated signiﬁcantly with cerebral vitamin C levels,
monoaminergic neurotransmitters and metabolites in the frontal cortex, but not in the hippocampus. Thus, a
high fat diet caused regional alterations in antioxidant levels, neurochemistry and molecular markers in the non-
obese dyslipidemic guinea pig.
1. Introduction
A Western diet characterized by a high fat/high caloric intake is
associated with dyslipidemia and obesity, but also with cognitive def-
icits such as psychiatric diseases and dementia in humans [20,37,53],
linking the current global pandemic of diet-imposed dyslipidemia and
obesity to negative consequences in the brain [10,38].
Reports from studies of animal models exposed to long term diets,
high in fat and/or sugar show reduced hippocampal memory functions
[33,46,52], increased anxiety and depression-like behavior [23–25], as
well as alterations of markers associated with Alzheimer’s disease
[18,48]. Several mechanisms have been implicated in dyslipidemia-
induced cognitive impairments, including a decrease in the important
growth factor, brain-derived neurotrophic factor (BDNF), altered sy-
naptic plasticity, as well as increased oxidative stress [8]. Particular
interest has been given to the eﬀects of Western diets on frontal cortex-
and hippocampus-dependent functions due to their involvement in
memory, emotions, decision making and spatial navigation [5,44].
Increased oxidative stress has been shown to reduce BDNF [21,52].
BDNF is an important growth factor in the development of brain cir-
cuitry and function and is involved in dendrite and synapse develop-
ment, memory formation, synaptic plasticity and neuronal survival
[7,9]. Thus, alterations of BDNF levels may in turn impact plasticity
markers such as synapsin 1 – involved in neurotransmitter release, sy-
napse formation and maturation [6] – and Ca2+/calmodulin-dependent
protein kinase II (CAMKII) – important in long-term potentiation, sy-
naptic plasticity and learning [17,41] – either through changes in ex-
pression levels or the degree of phosphorylation [4,33]. Furthermore, a
decreased availability of vitamin C (vitC) may not only promote oxi-
dative stress, but also directly impact synthesis and metabolism of
monoaminergic neurotransmitters [27,51].
Hence, diet-induced dyslipidemia can be speculated to reduce
neuronal signaling leading to reduced cognitive function. However,
results are conﬂicting as some studies report no or even positive eﬀects
on overall brain function during a Westernized dietary regime [26,31],
whereas other investigations report that cognitive deﬁcits precede
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obesity [22,35], suggesting that the state of dyslipidemia rather than
obesity per se may be the driving force of a cognitive decline. Conse-
quently, it is currently diﬃcult to assess any isolated eﬀects of either
dyslipidemia or obesity.
Interestingly, the lipoprotein proﬁle and markers associated with
Alzheimer’s disease are similar between guinea pigs and humans fol-
lowing a high fat/high cholesterol diet [3,12,43]. This study in-
vestigates the eﬀects of long term, high fat diet-induced dyslipidemia in
a non-obese guinea pig model on brain oxidative stress and potential
regional alterations of BDNF and related markers of synaptic plasticity,
as well as changes in levels of monoaminergic neurotransmitters. A
potentially exacerbated eﬀect by increased dietary sucrose in a high fat
diet was also explored.
2. Materials and methods
2.1. Animals
All experiments were approved by the Danish Animal Experiments
Inspectorate under the Ministry of Food, Agriculture and Fisheries and
in accordance with EU directive 2010/63/EU, as previously described
[19]. Tissue samples were utilized from a subset of animals included in
a larger in vivo study, of which some data has previously been published
[19]. In brief, female Hartley guinea pigs, 10 weeks of age (Charles
River Laboratories, Kissleg, Germany), were weight-stratiﬁed into
dietary groups receiving either ad libitum chow (CTRL, 4% fat, 0% su-
crose, 0% cholesterol), high fat (HF, 20% fat, 0% sucrose, 0.35% cho-
lesterol) or high fat, high sucrose (HFHS, 20% fat, 15% sucrose, 0.35%
cholesterol) diet and group housed in ﬂoor pens. A detailed diet com-
position is provided in Table 1. Hay and water was provided ad libitum
and animals were inspected daily by trained personnel. The animals
were weighed once a week. No animals displayed signs of reduced
welfare throughout the study period. After 25 weeks on the diets, the
animals (n=7 per group) were pre-anaesthetized with 0.08ml/kg
body-weight Zoletil-mix; Zoletil 50 (Virbac, Carros, France) supple-
mented with 0.75ml Torbugesic vet (10mg/ml, Scanvet, Fredensborg,
Denmark) and 10ml Rompun (10mg/ml, Bayer, Leverkusen, Germany)
diluted 1:10 in isotonic saline water and then placed on isoﬂurane
(Isoba Vet 100%, Intervet International, Boxmeer, The Netherlands).
After cessation of voluntary reﬂexes, intra-cardiac blood samples were
obtained and the animals euthanized by decapitation, as previously
described [19]. The brain was removed, rinsed in ice cold PBS,
weighed, divided and snap frozen. The frontal cortex and the hippo-
campus were dissected on ice. Plasma markers of dyslipidemia have
previously been published [19]. All animals appeared healthy and in
very good condition with no signs of malnutrition or disease at in-
spection and at necropsy.
2.2. Antioxidant turnover
The levels of total vitC, dehydroascorbate (DHA) – the oxidized
form of vitamin C – and resulting DHA% of total vitC in the frontal
cortex were determined in tissue homogenate stabilized with equal
amounts of meta-phos-phoric acid and as previously described [28].
Two animals were excluded for technical reasons.
2.3. Neurotransmitters
Monoaminergic neurotransmitters in the frontal cortex and the
hippocampus were analyzed by HPLC as previously described [42].
2.4. Protein extraction
Forty mg tissue from each of the frontal cortex and the hippocampus
were excised and subsequently homogenized in 500 μl cold RIPA buﬀer
(50mmol/l tris pH 8.0, 150mmol/l sodium chloride, 1% Triton X-100,
0.5% sodium deoxycholate and 0.1% sodium dodecyl sulfate) with
1:100 protease inhibitor cocktail and 1:100 phosphatase inhibitor
cocktail (Sigma-Aldrich, Darmstadt, Germany). The samples were cen-
trifuged for 10min at 12,000 rpm at 4 °C, the supernatant divided into
aliquots and stored at −80 °C. To determine protein concentration, a
commercially available BCA kit was used (Merck Millipore, Darmstadt,
Germany) [47].
2.5. ELISA
BDNF analyses were carried out by a commercial ELISA kit
(SEA011Gu, Cloud-Clone Corp, Houston, USA), as instructed by the
manufacturer. All samples were diluted 1:20 in sterile PBS to obtain an
Table 1
Exact dietary composition of the experimental diets.
Reproduced from Ipsen et al. [19].
Nutrients (g/kg diet) CTRL HF HFHS
Alfalfa 220 220 220
Wheat 283 290 103
Barley 180 – –
Sucrose – – 150
Cellulose (lignocellulose) 46.0 40.0 46.0
Sunﬂower meal 30.0 30.0 30.0
Soybean meal 120 70.0 60.0
Soybeans (full fat) 26.0 26.0 26.0
Soybean concentrate 20.0 80.0 120
Soybean isolate (90% protein) – – –
Amino acids 5.00 5.90 5.00
Vitamins & trace elementa 10.0 10.0 10.0
Vitamin C (Stay-C) 29.0 29.0 29.0
NaCl 4.0 4.0 4.0
Calcium phosphate (monobasic) 12.9 15.4 16.4
Calcium propionate 5.5 5.5 5.5
Calcium carbonate 2.5 1.5 1.5
Choline Cl 3.0 3.0 3.0
Sugar beet pulp 10.0 10.0 10.0
Cholesterol – 3.50 3.50
Coconut oil, hydrogenated – 180 180
Soybean oil 21.0 2.0 5.0
Crude protein 168 168 167
Crude fat 42 200 200
Crude ﬁber 126 113 114
Crude ash 65 65 66
Starch 279 189 77
Sugar 38 32 176
Carbohydrates 471 363 379
Fatty acids
C 6:0 – 0.6 0.6
C 8:0 – 9.9 9.9
C 10:0 – 9.3 9.3
C 12:0 – 81.9 81.9
C 14:0 0.2 35.4 35.4
C 16:0 6.3 22.9 22.7
C 18:0 1.6 21.9 22.0
C 20:0 0.2 0.3 0.3
C 16:1 0.3 0.1 0.1
C 18:1 8.7 5.3 5.6
C 18:2 21.9 10.0 9.8
C 18:3 3.7 2.3 2.2
a Vitamin & trace element content (addition per kg feed): 25.0 IU Vitamin A
(E672), 1.50 IU, Vitamin D3 (E671), 0.125 g Vitamin E (all-rac-alpha-toco-
pherylacetate) (3a700), 0.08 g Vitamin K3 (MNB), 0.08 g Vitamin B1 (Thiamine
mononitrate), 0.03 g Vitamin B2 (Riboﬂavin), 0.05 g Ca Pantothenate, 0.025 g
Vitamin B6 (pyridoxol hydrochloride) (3a831), 0.00015 g Vitamin B12
(Cyanocobalamine), 0.09 g Niacin, 0.009 g Folic acid, 0.0005 g Biotin, 0.100 g
Inositol, 0.100 g Iron (II)-sulfate monohydrate (E1), 0.005 Copper(II)-sulfate
pentahydrate (E4), 0.03 g Manganese (II)-sulfate monohydrate (E5), 0.002 g
Cobalt (II)-carbonate monohydrate (E3), 0.05 g Zinc sulfatemonohydrate (E6),
0.002 g Calcium iodate anhydrate (E2), 0.0001 g Sodium selenite (E8). CTRL:
Control diet, HF: High fat diet, HFHS: High fat, high sucrose diet.
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OD within the linear segment of the standard curve. All results were
normalized to protein concentration.
Amyloid Precursor Protein (APP) in the hippocampus was analyzed
by a commercial kit (EKA01603, Biomatik, Ontario, Canada), as in-
structed by the manufacturer. All samples were diluted 1:3 in sample
diluent, as determined by the standard curve. All results were nor-
malized to protein concentration. One animal was excluded for tech-
nical reasons.
2.6. Western blotting
Protein extracts from the frontal cortex and the hippocampus con-
taining 10 μg protein were adjusted to a volume of 11.25 μl before
adding 3.75 μl Laemmli Sample Buﬀer (Bio Rad, Hercules, CA, USA).
Samples were denatured at 70 °C for 10min and then transferred to a
7.5% Criterion™ TGX™ Precast Midi Protein Gel, (Bio Rad, Hercules,
CA, USA). The electrophoresis was run for app. 40 min before protein
transfer to a PVDF membrane (Bio Rad, Hercules, CA, USA) [47]. The
following antibodies were applied: Synapsin I (ab8; Abcam, Cambridge,
UK; 1:1000); CAMKII (Cba-2; Thermo Scientiﬁc, Waltham, MA, USA;
1:4000); phosphorylated CAMKII (p-CAMKII) (22B1; Thermo Scientiﬁc,
Waltham, MA, USA; 1:1000); phosphorylated synapsin 1 (p-synapsin 1)
(NB300-181; Novus Biologicals, Littleton, CO, USA; 1:1000); Anti-pre-
senilin 1 (ab76083; Abcam, Cambridge, UK; 1:5000); anti-Neuronal
nuclei protein (NeuN) (MAB377; Merck Millipore, Billerica, MA, USA;
1:2000) and anti-Glial Fibrillary Acidic Protein (GFAP) (ab7260;
Abcam, Cambridge, UK; 1:20,000). All antibodies were incubated at
4 °C o/n. Fluorescent secondary antibodies were incubated for 1 h at
RT: IRDye® 800CW Goat anti-Rabbit IgG (Li-Cor, Lincoln, NE,
USA;1:15,000) and IRDye® 680RD Donkey anti-Mouse IgG (Li-Cor,
Lincoln, NE, USA;1:15,000). All samples were run in duplicates. Cal-
culations of ﬂuorescence intensity were done by Image Studio 5.2 (Li-
Cor, Lincoln, NE, USA) and samples normalized to total protein levels
(REVERT™ Total Protein Stain, Li-Cor, Lincoln, NE, USA). One animal
was excluded from hippocampal GFAP, NeuN and presenilin 1 analysis
for technical reasons.
2.7. Statistics
The statistical analyses were performed in GraphPad Prism 7
(GraphPad Software, La Jolla, CA, USA) using one-way ANOVA.
Bodyweight was analyzed using SAS enterprise Guide 7.1 (SAS Institute
Inc, Cary, NC, USA) with a mixed linear model [19]. Spearman’s cor-
relation was computed to correlate the protein levels of total vitC, sy-
naptic plasticity markers and levels of monoamines with the previously
published plasma levels of triglycerides, cholesterol and low-density
lipoprotein. In the event of inhomogeneous variances, the data was log-
transformed and subsequently analyzed. Tukey’s multiple comparisons
test was used to correct for multiple comparisons. Results are presented
as mean ± SD, median and ranges or geometric mean with 95% con-
ﬁdence intervals. A p-value < 0.05 was considered statistically sig-
niﬁcant.
3. Results
Bodyweight during the entire study period is shown in Fig. 1 [19].
CTRL animals displayed an increased weight gain compared to HF and
HFHS animals and approached a plateau around week 16. HF and HFHS
animals displayed a consistent increase, but remained below CTRL. At
week 25 HF animals weighed less than CTRL (diﬀerence in mean
bodyweight: 69.4 g equating to 7.8%, p < 0.01), whereas HFHS ap-
proached the weight of CTRL (diﬀerence in mean bodyweight: 38 g
equating to 4.3%, p= 0.068). There was no diﬀerence in brain weight
(results not shown) in HF and HFHS groups compared with CTRL.
Plasma markers of dyslipidemia reﬂected dietary regimes (results
shown as geometric mean with 95% conﬁdence interval), as previously
published [19]: Plasma total cholesterol (mM) CTRL: 1.15 [0.92–1.45],
HF: 8.96 [7.17–11.30] and HFHS 9.38 [7.46–11.76]; plasma trigly-
cerides (mM) CTRL 1.03 [0.80–1.31], HF: 0.46 [0.35–0.58] and HFHS:
0.46 [0.35–0.58]; and low-density lipoprotein (mM) CTRL: 1.22
[0.92–1.62], HF: 9.04 [6.81–12.0] and HFHS: 7.86 [5.90–10.4]. In all
three markers of dyslipidemia, HF and HFHS diﬀered signiﬁcantly from
CTRL (p < 0.001). A decrease in vitC levels (CTRL:
1132 ± 52.3 nmol/mg tissue, HF: 925 ± 142.2 nmol/mg tissue,
HFHS: 969 ± 102.4 nmol/mg tissue) was evident in the frontal cortex
(CTRL vs. HF, p=0.0094; CTRL vs. HFHS p=0.0336), but no diﬀer-
ences between the experimental groups were detected in DHA and
DHA%. Total vitC in the frontal cortex correlated signiﬁcantly with
plasma triglycerides (p= 0.0039, Spearman’s r= 0.6019), low-density
lipoprotein (p=0.0233, Spearman’s r=−0.4925) and cholesterol
(p= 0.0310, Spearman’s r=−0.4714).
In the hippocampus, no diﬀerences in either of the monoaminergic
neurotransmitters, dopamine, norepinephrine and serotonin or the in-
vestigated metabolites were detected (Table 2). There was a signiﬁcant
increase in serotonin in frontal cortex in HF vs. CTRL (p= 0.0023) and
HF vs. HFHS (p=0.0479), while there was a tendency towards an in-
crease in 5-hydroxyindoleacetic (5-HIAA) acid in HF animals, albeit not
reaching signiﬁcance (CTRL vs. HF p=0.0547) (Table 2). BDNF was
decreased in the hippocampus of HFHS (CTRL vs. HFHS p= 0.0132)
(Fig. 2), while no changes were recorded in the frontal cortex. The ratio
of p-CAMKII to CAMKII was signiﬁcantly increased in the hippocampus
of HF animals (CTRL vs. HF p= 0.0415) (Fig. 3), but no changes in any
of the other plasticity markers were detected in the frontal cortex and
the hippocampus.
No changes were observed in NeuN, GFAP, PSEN1 and APP (results
not shown), but there was a tendency towards a decrease in PSEN1 in
the HF hippocampus (CTRL vs. HF p=0.0763).
In the frontal cortex, correlation analysis showed that the levels of
triglycerides in plasma correlated signiﬁcantly with 5-HIAA
(p= 0.0245, Spearman’s r=−0.4888), while low-density lipoprotein
correlated with levels of 3,4-dihydroxyphenylacetic acid (DOPAC)
(p= 0.0422, Spearman’s r= 0.447), homovanillic acid (HVA)
(p= 0.0019, Spearman’s r= 0.6381) and 5-HIAA (p=0.0175,
Spearman’s r= 0.5127), albeit did not reach signiﬁcant correlation
with serotonin (p= 0.0536, Spearman’s r= 0.4269). Plasma choles-
terol correlated signiﬁcantly with DOPAC (p=0.0310, Spearman’s
r= 0.4714), HVA (p=0.0017, Spearman’s r= 0.6429), 5-HIAA
(p= 0.0174, Spearman’s r= 0.513) and serotonin (p=0.0430,
Spearman’s r= 0.4455) in the frontal cortex. No signiﬁcant correla-
tions were detected between dyslipidemia and the remaining neuronal
Fig. 1. Changes in bodyweight during the study period. After week 16, half of
the animals in each group were euthanized and the remaining animals con-
tinued on their respective diets until week 25 (i.e. n=14/group for week 0–15,
and n= 7/group for week 16–25). There was a signiﬁcant eﬀect of time
(p < 0.001), diet group (p < 0.01) and diet group*time interaction
(p < 0.001). Data is depicted as mean ± SD, and was analyzed using a mixed
linear model. The original data has previously been published [17].
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markers.
4. Discussion
This study reports, that high fat diet-induced chronic dyslipidemia
decreases levels of vitC and increases serotonin in the frontal cortex,
while increasing the p-CAMKII/CAMKII ratio in the hippocampus. The
addition of sucrose to the HF diet abolishes the eﬀect on serotonin in
the frontal cortex and the p-CAMKII/CAMKII ratio in the hippocampus,
while decreasing BDNF in the hippocampus. Furthermore, markers of
dyslipidemia correlate with monoaminergic neurotransmitters and
metabolites in the frontal cortex. Importantly, these changes occur in
the absence of obesity, suggesting a direct eﬀect of an adverse diet and
the subsequent dyslipidemia on markers of brain function.
One of the mechanisms, through which Westernized diets have been
shown to elicit their damaging eﬀects, is by increasing oxidative stress
[34,45]. Both HF and HFHS diets led to lower levels of vitC in the
frontal cortex and markers of dyslipidemia directly correlated with total
vitC in the frontal cortex, suggesting a direct eﬀect of dyslipidemia on
cerebral vitC levels. We have previously found a high fat diet to de-
crease both cerebral vitC and glutathione, another important anti-
oxidant in the brain, in guinea pigs [15], while vitC deﬁciency itself
causes redox imbalances and oxidative damage to lipids and DNA
[29,36]. Thus, the decreases in cerebral vitC in the current study may
indicate a disruption of cerebral redox balance. However, this could not
be supported by a concurrent increase in DHA%. Low levels of vitC in
the brain have been associated with memory dysfunction [50], de-
mentia [11,54], and monoaminergic neurotransmitter changes [32,51]
in addition to increased oxidative stress [16,36], supporting vitC as a
crucial component in maintaining normal brain function. However,
vitC serves both as an unspeciﬁc antioxidant and a co-factor in speciﬁc
reactions such as the conversion of dopamine to norepinephrine [27]
and has been proposed to take an active part in preventing glutamate-
induced excitotoxicity [39]. It is possible, that an eﬀect of low brain
vitC levels in the current study would aﬀect these more speciﬁc path-
ways as opposed to overall redox imbalance. In the hippocampus, BDNF
levels appeared to be decreasing with dyslipidemia, albeit only
reaching signiﬁcance in the HFHS group. Other studies have shown a
negative eﬀect on BDNF expression following diets high in sugar and/or
fat, but most commonly in association with increased bodyweight
[33,46], which is not a feature of our model. The absence of obesity is
characteristic of the diet-induced dyslipidemic guinea pig model and
the recorded diﬀerences are likely to be reﬂecting a slight delay in
weight-gain in high fat fed animals [49]. We don’t know the reason for
this, but speculate that there may be a diﬀerence in preference between
the diets, inducing a higher intake of hay in the high fat fed animals. At
termination, groups are approaching similar levels in body weight in
coherence with the expected plateau of mature adult animals at this age
and supporting that the welfare of animals in HF and HFHS groups is
unaﬀected.
Despite a lower level of BDNF in the hippocampus of the HFHS
group, no additional diﬀerences in the selected plasticity markers were
detected. Whether this is due to BDNF levels still being suﬃciently high
to maintain downstream targets or that other BDNF regulated pathways
are aﬀected remains to be determined.
However, in the HF group, an increase in the p-CAMKII/CAMKII
ratio was detected in the hippocampus. Autophosphorylation of
threonine-286 gives the kinase an autonomous activity, independent of
Ca2+ levels, and is a key component of long-term potentiation and
memory formation [17]. The HF diet-imposed increase in the ratio of
autophosphorylated CAMKII could be interpreted as a beneﬁcial eﬀect
of HF on this plasticity marker. However, as a part of the p-CAMKII/
CAMKII increase is due to an overall decrease in total CAMKII, it may be
that the increased ratio is the result of combined eﬀects. Taken to-
gether, our ﬁndings indicate that dyslipidemia altered total CAMKII,
potentially imposing a negative eﬀect on long term potentiation andTa
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Fig. 2. Levels of selected molecular markers in
the frontal cortex and the hippocampus. (A)
BDNF in the frontal cortex and the hippo-
campus. Hippocampus: CTRL vs. HFHS
p=0.0132. (B) p-synapsin 1 to synapsin 1
ratio in the frontal cortex and the hippo-
campus. All values are presented as median and
range and were analyzed by one-way ANOVA
with Tukey’s multiple comparison test, n= 7.*:
p < 0.05. BDNF: Brain-derived neurotrophic
factor; SYN: synapsin 1; p-SYN: phosphorylated
synapsin 1; CTRL: Control diet, HF: High fat
diet, HFHS: High fat, high sucrose diet. Pictures
of representative Western blot bands are in-
cluded to conﬁrm band speciﬁcity. The two
bands seen at 70 and 74 kDa on the synapsin
and p-synapsin blots are consistent with splice
variants.
Fig. 3. Levels of p-CAMKII, CAMKII and the ratio in the frontal cortex and the hippocampus. p-CAMKII to CAMKII ratio in the hippocampus; CTRL vs. HF,
p= 0.0415. All values are presented as median and range and were analyzed by one-way ANOVA with Tukey’s multiple comparison test, n= 7.*: p < 0.05. CTRL:
Control diet, HF: High fat diet, HFHS: High fat, high sucrose diet; CAMKII: Ca2+/calmodulin-dependent protein kinase II; p-CAMKII: phosphorylated Ca2+/cal-
modulin-dependent protein kinase II. Pictures of representative Western blot bands are included to conﬁrm band speciﬁcity.
S.N. Hansen et al. Neuroscience Letters 676 (2018) 85–91
89
synaptic plasticity that subsequently induced a compensatory response
by increasing CAMKII-activation through phosphorylation. HF also in-
creased the levels of serotonin in the frontal cortex. Treatment with
selective serotonin reuptake inhibitors has previously been shown to
increase BDNF levels [1,14] and it may be that the increased serotonin
levels of the frontal cortex in the HF is a compensatory response to
maintain BDNF levels at normal. This, however, remains to be con-
ﬁrmed.
Correlation analysis showed that dyslipidemia inﬂuenced dopami-
nergic and serotonergic neurotransmitters and their metabolism (cor-
relation with 5-HIAA, serotonin, DOPAC and HVA) in the frontal cortex.
Dyslipidemia was also correlated with levels of total vitC in the frontal
cortex. VitC is involved in the synthesis of the monoaminergic neuro-
transmitters [13,30] and deﬁciency has been found to aﬀect their
synthesis and metabolism [32,51]. This supports, that dyslipidemia
may aﬀect levels of monoaminergic neurotransmitters by reducing VitC
levels. The eﬀect of dyslipidemia on the monoaminergic neuro-
transmitters was conﬁned to the frontal cortex, a brain area critical in
working memory, higher executive functions and mood [44], rendering
imbalances in neurotransmitter function to possibly impact these
functions. Working memory functions have been found to be impacted
directly by Westernized diets [22], primarily through eﬀects on hip-
pocampus-dependent cognitive functions [33,46,52].
Western diets have been shown to exacerbate the development of
dementia and Alzheimer’s disease in animal models and humans
[18,40,48]. Guinea pigs have similarities with human APP sequence
and processing and genes associated with Alzheimer’s disease have
been shown to increase during a high cholesterol dietary regime [2,43].
However, despite a tendency towards decreased presenilin 1 in the HF
group, we did not ﬁnd signiﬁcant changes in the investigated markers.
This was also the case in the current correlation analysis, where hip-
pocampal PSEN1 and APP approached, but did not reach signiﬁcant
correlation, with markers of dyslipidemia. This could be due to the
relatively young age of our animals, 35 weeks old at study termination.
Considering a lifespan of 5–6 years, these animals were still young
adults, well away from old age and senescence most commonly asso-
ciated with this type of neurodegenerative disorder.
In conclusion, this study reports that diet-induced dyslipidemia af-
fects antioxidant levels, neurochemistry and molecular markers in a
region-speciﬁc manner in the brain. Interestingly, these changes oc-
curred in the absence of obesity, suggesting that these eﬀects are a
direct, rather than indirect, consequence of a high fat diet and the as-
sociated dyslipidemia.
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